Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | Cell Line | log10[max. dose (M)] | R^2 (goodness of fit) | log10[EC50 (M)] | log10[IC50 (M)] | log10[GI50 (M)] | HillSlope | E_inf | E_max | AUC |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK461364 | MDA-MB-157 | -4.4776 | 0.9444 | -9.0436 | -8.9391 | -9.0610 | 2.6360 | 0.2340 | 0.2340 | 3.5893 |
| Torkinib | MDA-MB-453 | -4.3010 | 0.9696 | -8.2960 | -7.7064 | -9.1458 | 0.3729 | 0.1987 | 0.2238 | 4.2257 |
| Ixabepilone | MDA-MB-231 | -4.4045 | 0.9286 | -9.2455 | -9.2112 | -9.2591 | 1.4930 | 0.1324 | 0.1324 | 2.3981 |
| Torkinib | UACC-893 | -4.3010 | 0.9509 | -7.8850 | -7.5857 | -9.2978 | 0.3751 | 0.1139 | 0.1523 | 4.1641 |
| Torkinib | HCC1428 | -4.3010 | 0.7953 | -7.7250 | -7.4406 | -9.2993 | 0.2643 | 0.0796 | 0.1814 | 4.2525 |
| Torkinib | T47D | -4.3010 | 0.9460 | -9.4110 | -8.5983 | -9.5701 | 0.4377 | 0.2796 | 0.2838 | 3.7359 |
| Torkinib | MDA-MB-134-VI | -4.3010 | 0.9644 | -8.3700 | -8.1441 | -9.5949 | 0.3310 | 0.0793 | 0.1189 | 3.4999 |
| Torkinib | T47DKBLUC | -4.3010 | 0.9063 | -9.3870 | -5.1956 | -9.6065 | 0.4163 | 0.4910 | 0.4949 | 5.3140 |
| Torkinib | HCC38 | -4.3010 | 0.9596 | -8.9020 | -8.8385 | -9.6108 | 0.5908 | 0.0409 | 0.0428 | 2.3342 |
| Torkinib | HCC2185 | -4.3010 | 0.9758 | -8.3570 | -7.4396 | -9.6944 | 0.4359 | 0.3010 | 0.3127 | 4.7229 |
| Torkinib | UACC-812 | -4.3010 | 0.9736 | -8.7280 | -7.8546 | -10.2600 | 0.3573 | 0.2563 | 0.2753 | 4.2197 |
| Torkinib | MCF7 | -4.3010 | 0.9482 | -10.1570 | -9.6593 | -10.3750 | 0.4305 | 0.1950 | 0.1974 | 2.6031 |
| Torkinib | ZR-75-1 | -4.3010 | 0.9479 | -9.8430 | -8.9499 | -10.7280 | 0.5030 | 0.3223 | 0.3234 | 3.6921 |
| Torkinib | HCC70 | -4.3010 | 0.9415 | -9.6690 | -9.5655 | -12.1070 | 0.3058 | 0.0350 | 0.0565 | 2.0727 |